Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform.

Persist AI

Karthik Raman

Persist assist pharmaceutical companies in developing long-acting formulations 50% faster. Because the formulation development process is manual and relies on scientific intuition, it takes a pharmaceutical company 5-10 years to develop a long acting formulation for a drug. This effort is divided into five years of pre-clinical development and five years of clinical testing. Their goal is to use machine learning and automation to reduce the time required for pre-clinical formulation development to three months, making the formulation development process 50% faster.

Artificial Intelligence Companies

Software Companies

Bioinformatics Organizations

Christopher Shelner

Y Combinator

2048 Ventures

Pioneer Fund

Financial services company based in San Francisco, California

Fellows Fund

Innospark Ventures

Venture capital firm investing in AI startups

Jovono

Woodland

City in Yolo County, California, United States

United States of America

Country primarily located in North America

California

Yolo County

Custom Computer Programming Services

Computer Systems Design and Related Services

Professional, Scientific, and Technical Services

Software Publishers

Publishing Industries

Information

Publishing Industries (except Internet)

Computer Programming Services

Computer Programming, Data Processing, And Other Computer Related

Business Services

Prepackaged Software

Biotechnology company for long-acting formulations

Polyfill

web-vitals

Sectigo

React

Google Cloud Platform

sentry

lodash

Neural network

Persist AI

Company Details

Founded

Employees

Raised

Headquarters Location

Public

Acquired

CEO

Founders

Company Collections

Persist AI's Investors

Persist AI's Industries

💸 Investors

📚 Popular Blog Posts